Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Chenglan Lv"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundMultiple myeloma (MM) remains an essentially incurable disease. This study aimed to establish a predictive model for estimating prognosis in newly diagnosed MM based on gene expression profiles.MethodsRNA-seq data were downloaded from the M
Externí odkaz:
https://doaj.org/article/fa92315cc06448eba4c051d033fe0f70
Publikováno v:
Therapeutic Advances in Hematology, Vol 13 (2022)
Background: Primary central nervous system lymphoma (PCNSL) has received more attention because of an inferior prognosis. Less is known about the incidence rate, histological type, and survival rate of PCNSL, especially in the 2010s. Methods: Data of
Externí odkaz:
https://doaj.org/article/3837a7945e4f44c1871806f4dd02da81
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4919
As the survival times for multiple myeloma (MM) patients continue to extend, the risk of a second primary malignancy (SPM) among MM survivors has become a topic of increasing concern within the medical community. The Surveillance, Epidemiology, and E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4efbabc447ffa0dd413d5fa9a31a187e
https://pubmed.ncbi.nlm.nih.gov/36230842
https://pubmed.ncbi.nlm.nih.gov/36230842
Publikováno v:
IUBMB Life
N6-methyladenosine (m6A) regulators play an important role in tumorigenesis; however, their role in multiple myeloma (MM) remains unknown. This study aimed to create an m6A RNA regulators prognostic signature for MM patients. We integrated data from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::930bb1f18364faa988ce0ada8f97650a
https://pubmed.ncbi.nlm.nih.gov/36177774
https://pubmed.ncbi.nlm.nih.gov/36177774
Publikováno v:
OncoTargets and therapy
Primary central nervous system lymphoma (PCNSL) is a rare subtype of extranodal non-Hodgkin lymphoma, and the most frequent histological type is diffuse large B‐cell lymphoma (DLBCL). Bruton’s tyrosine kinase inhibitor (BTKi) has shown clinical a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505f7720be8f004c06b6b040d2817b62
http://europepmc.org/articles/PMC8163630
http://europepmc.org/articles/PMC8163630
Publikováno v:
SSRN Electronic Journal.
BackgroundN6-methyladenosine (m6A) regulators play a critical role in tumorigenesis; however, their role in multiple myeloma (MM) remains unknown. This study aimed to create an mRNA prognostic signature based on the m6A regulators status of in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34c9a5bc3bb522750c9593a3736b486e
https://doi.org/10.2139/ssrn.3857598
https://doi.org/10.2139/ssrn.3857598
Publikováno v:
Medicine. 100:e24824
Introduction There is currently no optimal treatment modality for refractory or relapsed Extranodal NK/T-cell lymphoma, nasal type (ENKTL). In recent years, programmed cell death protein 1 (PD-1)/programmed cell - ligand 1 pathway blockade and histon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fca1f758185f320f27e2600459259e9
https://doi.org/10.1097/md.0000000000024824
https://doi.org/10.1097/md.0000000000024824
Autor:
Jingyan Xu, Xihui Xu, Jieyu Chen, Jing Wang, Chong Jiang, Chenglan Lv, Bing Chen, Xu, Jingyan, Xu, Xihui, Chen, Jieyu, Wang, Jing, Jiang, Chong, Lv, Chenglan, Chen, Bing
Publikováno v:
Medicine; 3/12/2021, Vol. 100 Issue 10, p1-5, 5p